[HTML][HTML] Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid …
A Scardocci, M Caira, G Gianfaldoni, G Leone - Annals of Oncology, 2008 - Elsevier
Background Gemtuzumab ozogamicin (GO) is effective as single agent in the treatment of
acute myeloid leukemia (AML). We evaluated efficacy and safety of a chemotherapy …
acute myeloid leukemia (AML). We evaluated efficacy and safety of a chemotherapy …
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia
L Fianchi, L Pagano, F Leoni, S Storti… - Annals of …, 2008 - annalsofoncology.org
Background Gemtuzumab ozogamicin (GO) is effective as single agent in the treatment of
acute myeloid leukemia (AML). We evaluated efficacy and safety of a chemotherapy …
acute myeloid leukemia (AML). We evaluated efficacy and safety of a chemotherapy …
Gemtuzumab ozogamicin, cytosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia.
L Fianchi, L Pagano, F Leoni, S Storti… - Annals of Oncology …, 2007 - europepmc.org
Background Gemtuzumab ozogamicin (GO) is effective as single agent in the treatment of
acute myeloid leukemia (AML). We evaluated efficacy and safety of a chemotherapy …
acute myeloid leukemia (AML). We evaluated efficacy and safety of a chemotherapy …
Gemtuzumab ozogamicin, cytosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia
L Fianchi, L Pagano, F Leoni, S Storti… - Annals of oncology …, 2008 - pubmed.ncbi.nlm.nih.gov
Background Gemtuzumab ozogamicin (GO) is effective as single agent in the treatment of
acute myeloid leukemia (AML). We evaluated efficacy and safety of a chemotherapy …
acute myeloid leukemia (AML). We evaluated efficacy and safety of a chemotherapy …
Gemtuzumab ozogamicin, cytosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia
L Fianchi, L Pagano, F Leoni, S Storti… - ANNALS OF …, 2008 - art.torvergata.it
Gemtuzumab ozogamicin (GO) is effective as single agent in the treatment of acute myeloid
leukemia (AML). We evaluated efficacy and safety of a chemotherapy including growth …
leukemia (AML). We evaluated efficacy and safety of a chemotherapy including growth …
[PDF][PDF] Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia
L Fianchi, L Pagano, F Leoni, S Storti, MT Voso… - Annals of …, 2008 - academia.edu
original article Page 1 Annals of Oncology 19: 128–134, 2008 doi:10.1093/annonc/mdm451
Published online 28 September 2007 original article Gemtuzumab ozogamicin, citosine …
Published online 28 September 2007 original article Gemtuzumab ozogamicin, citosine …
[引用][C] Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia
L Fianchi, L Pagano, F Leoni, S Storti, MT Voso… - Annals of …, 2007 - irep.ntu.ac.uk
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment
of elderly patients with poor-prognosis acute myeloid leukemia - IRep - Nottingham Trent …
of elderly patients with poor-prognosis acute myeloid leukemia - IRep - Nottingham Trent …
[引用][C] Gemtuzumab ozogamicin, cytosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia
L FIANCHI - Ann Oncol, 2008 - cir.nii.ac.jp
Gemtuzumab ozogamicin, cytosine arabinoside, G-CSF combination (G-AraMy) in the treatment
of elderly patients with poor-prognosis acute myeloid leukemia | CiNii Research CiNii 国立 …
of elderly patients with poor-prognosis acute myeloid leukemia | CiNii Research CiNii 国立 …
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia
L Fianchi, L Pagano, F Leoni, S Storti, MT Voso… - Annals of …, 2008 - elibrary.ru
Background: Gemtuzumab ozogamicin (GO) is effective as single agent in the treatment of
acute myeloid leukemia (AML). We evaluated efficacy and safety of a chemotherapy …
acute myeloid leukemia (AML). We evaluated efficacy and safety of a chemotherapy …
[PDF][PDF] Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia
L Fianchi, L Pagano, F Leoni, S Storti, MT Voso… - Annals of …, 2008 - cyberleninka.org
original article Page 1 Annals of Oncology 19: 128–134, 2008 doi:10.1093/annonc/mdm451
Published online 28 September 2007 original article Gemtuzumab ozogamicin, citosine …
Published online 28 September 2007 original article Gemtuzumab ozogamicin, citosine …